(Q37949098)

25 August 2017

title

Relevance of RH variants in transfusion of sickle cell patients (English)

1 reference

25 August 2017

0 references

F Noizat-Pirenne

1

1 reference

25 August 2017

C Tournamille

series ordinal

2

1 reference

25 August 2017

publication date

22 October 2011

1 reference

Transfusion Clinique et Biologique

25 August 2017

published in

1 reference

25 August 2017

volume

18

1 reference

25 August 2017

issue

5-6

1 reference

25 August 2017

page(s)

527-535

1 reference

Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Current issues with blood transfusions in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

[Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Red blood cell alloimmunization in sickle cell disease patients in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Rh complexities: serology and DNA genotyping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

7 January 2021

Molecular blood grouping

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Future of molecular testing for red blood cell antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Blood group genotyping: from patient to high-throughput donor screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Red cell genotyping and the future of pretransfusion testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Molecular genetic basis of the human Rhesus blood group system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

RHCE represents the ancestral RH position, while RHD is the duplicated gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Molecular genetics of RH and its clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Partial D and weak D: can they be distinguished?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Molecular background of VS and weak C expression in blacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

The DAU allele cluster of the RHD gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

How I manage donors and patients with a weak D phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

RHD allele distribution in Africans of Mali

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

A novel RHCE*ce 48C, 733G allele with Nucleotide 941C in Exon 7 encodes an altered red blood cell e antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Alloanti-c in a c-positive, JAL-positive patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Alloanti-c (RH4) revealing that the (C)ce s haplotype encodes a partial c antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Delayed hemolytic transfusion reaction due to anti-Goa, an antibody against the low-prevalence Gonzales antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

DAK, a new low‐incidence antigen in the Rh blood group system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Delayed hemolytic transfusion reaction in children with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Analysis of RhCE variants among 806 individuals in France: considerations for transfusion safety, with emphasis on patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

Risk factors for alloimmunization by patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2011.09.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRACLI.2011.09.001

1 reference

25 August 2017

1 reference